The 2020 results from trials of minimally invasive glaucoma surgery (MIGS) device MINIjectTM will be presented at the upcoming European Glaucoma Society (EGS) annual meeting on 12-13 December. The consistently positive data showed outstanding results of intraocular pressure (IOP) and medication reduction in patients with open angle glaucoma, and a positive safety profile across trials. […]
MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, has been presented as part of the ‘Emerging Technologies’ session at the prestigious 2020 virtual Interventional Glaucoma Congress (IGC) meeting. Dr Paul Singh, who presented iSTAR Medical’s technology, is a glaucoma specialist, President of The Eye Centers of Racine & Kenosha (Wisconsin, USA) and one of […]
iSTAR Medical has been awarded the 2020 BVA Venture Company of the Year at the BVA Award virtual ceremony today. The BVA Award is organised by the Belgian Venture Capital & Private Equity Association to reward and celebrate high-performing Belgian companies backed by private equity or venture capital funds. “We are honoured and excited by […]
https://www.istarmed.com/wp-content/uploads/2020/10/BVA-winner5.png242800Katherin Awadhttp://www.istarmed.com/wp-content/uploads/2020/10/Logo-iSTAR-Med-web-300x138.pngKatherin Awad2020-10-29 18:00:412020-10-30 06:21:19iSTAR Medical wins BVA Award 2020!
CEO Michel Vanbrabant will illustrate the latest results for iSTAR Medical’s minimally-invasive glaucoma surgery (MIGS) device MINIject at the Glaucoma Innovation Showcase today. iSTAR Medical was selected as one of eight companies to showcase innovative glaucoma treatments to prospect investors at today’s meeting organised by the Ophthalmology Innovation Summit (OIS). iSTAR Medical recently announced consistently […]